Report this content

Oslo, Norway (19th June 2018) – In conjunction with the hiring of the new Senior Vice President Global Sales & Marketing in NattoPharma and based on the power of attorney granted at the annual general meeting of NattoPharma ASA ("NattoPharma" or "Company") on May 30th, 2018, the Board of Directors of NattoPharma has in board proceedings June 19th, 2018 granted a total of 30,000 options to Christopher Speed who started in the new position on June 18th, 2018. Mr. Speed holds no shares or options in NattoPharma ASA prior to this grant. His total holding of shares and options following this grant is 30,000 options.

The options have an exercise price equal the closing price on Oslo Axess on June 19th, 2018, which is equal to NOK 8,80.

The options granted are fully vested on December 16th, 2018 and may be exercised up to and including March 31st, 2023.

* * *

For more information, please contact:

Kjetil Ramsøy,

CEO/CFO, NattoPharma


This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

This information is information that NattoPharma ASA (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication through the agency of the contact person set out above at 21:00 pm CET on June 19th, 2018.

Documents & Links